Daily non-political popular news in brief.

Jefferson scientists find rabies-based vaccine could be effective against HIV

Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease. Early evidence indicates that the vaccine -- which doesn’t protect against infection -- prevents development of disease. Two years after the initial vaccination, four non-human primates were protected from disease, even after being "challenged" with a dangerous animal-human virus.

Read more »

Keywords: jefferson, scientists, rabies-based, vaccine, effective, hiv, scientist, rabies, based

« Previous | Next »

Similar news on "Jefferson scientists find rabies-based vaccine could be effective against HIV":

1. Potent Peptides Inhibit HIV Entry Into Cells
   10-08-2007 · Brookhaven National Laboratory
   Based in part on protein structures determined at the National Synchrotron Light Source (NSLS) at Brookhaven, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class.
   Similar news · Read more »
   
2. The quest for an effective HIV vaccine presents new possibilities, challenges
   05-16-2007 · EurekAlert!
   A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at NIAID. Rather, the first successful preventive HIV vaccines, if administered prior to HIV infection, may reduce HIV levels in the body, thereby delaying the progression to AIDS and the need to start antiretroviral drugs.
   Similar news · Read more »
   
3. Potent peptides inhibit HIV entry into cells
   10-10-2007 · EurekAlert!
   Based in part on protein structures determined at the National Synchrotron Light Source at the US Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class. These peptides are sufficiently potent to begin preclinical studies as a new class of agents for the prevention and treatment of HIV/AIDS.
   Similar news · Read more »
   
4. New picture of HIV-1's protein jacket identifies target for antibody-based vaccine
   01-10-2008 · EurekAlert!
   By coaxing the HIV-1 protein to reveal a hidden portion of its protein coat, scientists at Dana-Farber Cancer Institute and Harvard Medical School have provided a newly detailed picture of how protective, or so-called broadly neutralizing, antibodies block HIV-1 infection. The discovery may provide scientists with an attractive target for antibody-based vaccine.
   Similar news · Read more »
   
5. Scientists solve mystery of how malaria hijacks red blood cells
   01-15-2007 · EurekAlert!
   Northwestern University researchers have uncovered how malaria parasites break into red blood cells and how to block the invading parasites with a commonly prescribed high-blood pressure medication. This opens the door for important new drugs to which the parasites are much less likely to become resistant. Malaria is surging worldwide because of drug resistance and the lack of an effective vaccine. Jamaica, which had eradicated the disease for 50 years, recently reported an outbreak.
   Similar news · Read more »
   
6. Scripps research scientists develop innovative dual action anthrax vaccine-antitoxin combination
   10-04-2007 · EurekAlert!
   Scientists at the Scripps Research Institute and the Salk Institute for Biological Studies have developed a new and highly effective agent that provides protection against anthrax by combining a fast-acting anthrax toxin inhibitor with a vaccine in a single compound.
   Similar news · Read more »
   
7. Uncovering the Achilles' heel of the HIV-1 envelope
   01-11-2008 · EurekAlert!
   New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine.
   Similar news · Read more »
   
8. Harvard scientists partner to develop and distribute new tuberculosis vaccine
   02-17-2007 · EurekAlert!
   Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods. The process could one day provide a better approach for vaccination against TB and help prevent the related spread of HIV/AIDS in the developing world.
   Similar news · Read more »
   
9. Jefferson researchers' discovery may change thinking on how viruses invade the brain
   04-19-2007 · EurekAlert!
   A molecule thought crucial to ferrying the deadly rabies virus into the brain, where it eventually kills, apparently isn't. Instead, the protein complex LC8 is actually involved in virus reproduction. The surprising finding, say researchers at Jefferson Medical College in Philadelphia, may change the way scientists think about how central nervous system-attacking viruses such as herpes viruses invade the brain and cause disease.
   Similar news · Read more »
   
10. Forsyth scientists wiping out tooth decay through school-based cavities prevention program
    03-22-2007 · EurekAlert!
    Forsyth Institute scientists are reporting that they have developed an effective program for virtually eliminating cavities. This program, called ForsythKids, is an innovative school-based cavity prevention program, which provides elementary school children with oral health education, dental exams, cleanings and preventive care.
    Similar news · Read more »